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Introduction: Canonical Wnt signalling and increased β-catenin activity
have been implicated in the process of cartilage degradation in osteoarthri-
tis (OA). Increased Wnt-induced signalling protein 1 (WISP1) in OA cartilage
induces cartilage degradation by upregulating matrix metalloproteinases
(MMPs) and aggrecanases (ADAMTS-4 and ADAMTS-5). Wnt signalling is
inhibited by endogenous antagonists dickkopf-1 (DKK1), secreted frizzled-
related proteins (sFRP) and sclerostin (SOST). Despite increased chondrocyte
β-catenin promoting cartilage degradation, insuﬃciency of sFRPB failed to
alter OA cartilage damage in mice, and inhibition of DKK1 reduced rather
than increased cartilage damage in a surgical model of OA in rats. These
conﬂicting results demonstrate the complexity of Wnt-β-catenin regula-
tion. SOST is a potent Wnt-β-catenin antagonist and a key regulator of
bone metabolism but no previous studies have investigated its role in OA
pathology.
Methods: SOST, WISP-1 and β-catenin were immuno-localised in osteo-
chondral sections of surgically-induced OA in sheep and mice, as well as
human tibial plateaus obtained at arthroplasty for OA. Expression of Sost,
Wisp-1, β-catenin, Lrp-5/6, Dkk1, Mmp-1 & -13, Adamts-4 & -5, Timp-1 &
-3, aggrecan and collagen II by chondrocytes in OA, and with stimulation
by 10ng/ml interleukin-1α (IL-1) or 100ng/ml tumor necrosis factor-α (TNF)
in culture, was quantiﬁed by real-time RT-PCR. The effect of 25-500ng/ml
rhSOST on cartilage degradation and chondrocyte gene expression was
examined in explant culture.
Results: Contrary to being osteocyte-speciﬁc, Sost mRNA was expressed by
articular chondrocytes in all species, and was upregulated in OA in mice and
by IL-1 but not TNF in culture. Chondrocyte SOST protein was signiﬁcantly
increased only in the focal area of cartilage damage in surgically-induced
OA in sheep and mice, as well as end-stage human OA. In contrast,
osteocyte SOST was focally decreased in the subchondral bone in OA in
association with increased bone sclerosis. SOST was biologically active in
chondrocytes, increasing expression of Mmp-13 from as early as 4 hours
and maintained to 24 hours. At 48 hours, exogenous SOST decreased mRNA
levels of aggrecan and type II collagen, inhibited Wnt-β-catenin signalling
and down-regulated Mmp-13, Adamts-5 and Timp-1 and Timp-3 expres-
sion. SOST augmented IL-1’s stimulatory effects on chondrocyte Mmp-1,
Adamts-4 and Adamts-5, and its inhibition of aggrecan and collagen II
expression.
Conclusions: Taken together, this data suggests that SOST may actively
participate in the pathological progression of OA by affecting both cartilage
and subchondral bone. The differential change in SOST in cartilage and
subjacent bone highlight the potential tissue/cell speciﬁc regulation of
Sost, and the opposing effects of altering Wnt-β-catenin activity in bone
and cartilage. Overall the effects of SOST in cartilage are pro-catabolic,
with inhibition of aggrecan, collagen II and Timp expression, and acute
upregulation of Mmp-13. In bone, SOST increases osteoblast activity and
bone formation, and inhibition of SOST and DKK1 have potential in treating
osteoporosis. In light of this and the multiple potential mechanisms of
action of SOST, it will be important to determine what effect its inhibition
may have on progression of both bone and cartilage changes in OA in vivo.
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INDUCTION OF INFLAMMATORYMEDIATORS AND MATRIX
DEGRADATION IN ARTICULAR CARTILAGE BY TENASCIN-C AND TLR4
SIGNALING
L. Patel, W. Sun, K.E. Georgiadis, E.A. Morris, C.R. Flannery,
P.S. Chockalingam
Pﬁzer, Cambridge, MA
Purpose: Tenascin-C (TNC) is a modular, multifunctional extracellular ma-
trix glycoprotein that is involved in tissue injury and repair processes. TNC
plays a major role in cell adhesion, migration, proliferation, and cellular
signaling. TNC stimulates the production of pro-inﬂammatory cytokines in
human macrophages and synovial ﬁbroblasts through activation of Toll-like
receptor-4 (TLR4) (Midwood et al, Nat Med 2009). We have previously
demonstrated that elevated levels of TNC may be a sensitive biomarker of
joint disease/injury in synovial ﬂuids from human patients and preclinical
animal models. In the current study, we compared cartilage mRNA and
protein levels of TNC under normal and diseased conditions, and evaluated
the capacity for TNC and TLR signaling pathways to induce inﬂammatory
mediators and matrix degradation in articular cartilage.
Methods: Specimens of human osteoarthritic (OA) cartilage were obtained
from patients undergoing knee replacement surgery (New England Baptist
Hospital), and non-OA human cartilage was from tissue donors with no
history of joint disease (NDRI). TNC was measured in human cartilage
extracts and bovine cartilage explant culture media using an ELISA kit
(IBL). Human TNC was from Millipore, and rough LPS was from Axxora.
Bovine cartilage explant cultures were used to study the effect of IL-1α on
TNC expression, and the impact of TNC and LPS treatments on the release
of sulfated glycosaminoglycan (sGAG). Chondrocyte/explant conditioned
media were also assayed using ELISA kits for IL-6 (Thermo Scientiﬁc), PGE2
(R&D Systems) and nitrate (Cayman). TNC, ADAMTS4, MMP13, aggrecan,
type II collagen and GAPDH Taqman assays were performed using one step
RT-PCR with primer probes from Applied Biosystems. TAK242, a speciﬁc
TLR4 inhibitor (Takashima et al, Br J Pharmacol 2009), was synthesized and
tested in chondrocyte and explant culture studies.
Results: Human OA cartilage extracts had ∼8-fold more TNC protein
relative to non-OA cartilage extracts. TNC mRNA expression was elevated
∼6-fold in human OA cartilage compared to non-OA cartilage. Treatment
of human OA chondrocytes with TNC (10μg/ml) or LPS (1μg/ml) signiﬁ-
cantly induced the production of IL-6 and PGE2 (∼10,000- and ∼5,000-fold
increase, respectively), and nitrate release was also upregulated (up to
5-fold). Induction of IL-6, PGE2, and nitrate secretion was dose-dependently
reduced by addition of TAK242 (0.01-1μM). In bovine chondrocyte cultures,
expression of ADAMTS4 and MMP13 mRNA was induced by TNC and LPS
(∼28- and ∼58-fold increase, respectively), whereas type II collagen and
aggrecan expression was downregulated. TNC- and LPS-dependent modu-
lation of gene expression was also suppressed by the addition of TAK242.
Addition of TNC or LPS stimulated the release of sulfated glycosaminogly-
can from bovine explants, and this degradative response was inhibited by
TAK242. To demonstrate that preparations of TNC were not contaminated
with LPS, heat killed TNC served as a negative control in these studies
and did not cause any effect. Addition of ILα to bovine explant cultures
increased TNC release in a dose dependent manner indicating synthesis of
TNC by chondrocytes in response to inﬂammatory stimuli.
Conclusions: Elevated levels of TNC protein and mRNA expression in
OA cartilage correlated with our previous observations of increased TNC
levels in the synovial ﬂuid of OA patients (mean of 0.85μg/ml; range of
0.07-3.72μg/ml) compared to reference subjects (mean of 0.12μg/ml; range
of 0.003-0.59μg/ml). TNC was recently identiﬁed as a DAMP (damage-
associated molecular pattern) activating TLR4 in inﬂammatory diseases. In
the current studies, TNC or LPS caused an elevation in matrix degrading
enzymes and accelerated matrix degradation through TLR4 signaling in
articular cartilage, suggesting that therapeutic strategies impacting this
pathway may be applicable for the treatment of joint disorders.
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ALLELIC EXPRESSION ANALYSIS OF THE GENES WITHIN THE
CHROMOSOME 7q22 OA SUSCEPTIBILITY LOCUS REVEALS EVIDENCE FOR
FUNCTIONAL POLYMORPHISM IN COG5
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Newcastle Univ., Newcastle upon Tyne, United Kingdom
Purpose: A highly signiﬁcant association of an OA susceptibility locus has
recently been reported at chromosome 7q22, to a region of high linkage
disequilibrium (LD) encompassing six known genes: PRKAR2B, HBP1, COG5,
GPR22, DUS4L and BCAP29. It is becoming increasingly apparent that most
common disease susceptibility loci harbour causal polymorphisms that
regulate expression of the gene - so called expression quantitative trait loci
(eQTLs). As a means of dissecting apart the six OA candidates from within
the high LD block we have searched for eQTLs that could account for the
OA association signal.
Methods: Using a panel of human cell lines, including chondroytic, os-
teoblastic, and lipocytic cells, and OA patient joint tissues, including
cartilage, meniscus, fat pad, synovium, tendon, ligament and osteophyte,
we measured both the overall amount of gene expression, by quantitative
real-time PCR, and the allelic expression of the genes, using transcript SNPs
identiﬁed by direct DNA sequencing and an allelic expression assay that
